Axsome Therapeutics Inc. (0HKF)
LSE
168.69
-7.20 (-4.09%)
Closed
Oct 8, 2026
Day's Range
166.25175.20
52 wk Range
117.94263.93
Financial Statements - 0HKF - Axsome Therapeutics Inc.
Revenue
19.17M▲ 93.2%
Net Income
-6.54M▲ 13.1%Net Margin -34.1%
EBITDA
-3.99M▲ 6.9%
Free Cash Flow
-11.86M▼ 36.7%
Income Statement
| Period Ending | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|
| Sales | 19.17M | 9.92M | 13.66M | 4.89M |
| Cost of Goods | 14.84M | 7.66M | 9.59M | 2.94M |
| Gross Profit | 4.32M | 2.26M | 4.07M | 1.94M |
 Operating Expense | - | - | - | - |
| Operating Income | -4.39M | -4.60M | -800K | -4.93M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | 546K | -256K | 5M | 4.21M |
| Pre Tax Income | -6.54M | -7.53M | 1.11M | -2.83M |
| Income Tax | - | - | - | 0 |
| Net Income | -6.54M | -7.53M | 1.11M | -2.83M |
| EPS Basic | - | -0.05 | 0.01 | -0.03 |
| EPS Diluted | - | -0.05 | 0.01 | -0.03 |
| Basic Shares Outstanding | - | 139.89M | 119.62M | 106.99M |
| Diluted Shares Outstanding | - | 139.89M | 119.62M | 106.99M |
| Ebit | - | - | - | - |
| Ebitda | -3.99M | -4.29M | -591K | -4.82M |
| Net Income Continuous Operations | -6.54M | -7.53M | 1.11M | -2.83M |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
